Table 1. Effects of FIN on general intake measures and bout dynamics during FIN treatment, early withdrawal, and late withdrawal phases.

All values represent the mean ± SEM of each treatment phase for n = 7 VEH-treated mice, n = 8 FIN-50 mice, and n = 8 FIN-100 mice.

	Experimental Phase
	FIN Treatment	Early Withdrawal	Late Withdrawal
10E Licks
VEH	445 ± 107	698 ± 196	796 ± 180
FIN-50	207 ± 91*	396 ± 163	531 ± 160
FIN-100	97 ± 29**	344 ± 166	399 ± 173
10E Preference Ratio
VEH	0.84 ± 0.05	0.87 ± 0.04	0.94 ± 0.01
FIN-50	0.48 ± 0.09***	0.65 ± 0.13	0.83 ± 0.08
FIN-100	0.41 ± 0.05***	0.70 ± 0.07	0.77 ± 0.10
Total Fluid Intake (licks/2-hr)
VEH	529 ± 127	821 ± 229	837 ± 186
FIN-50	360 ± 139	513 ± 160	578 ± 166
FIN-100	230 ± 81	432 ± 193	465 ± 176
Inter-Session Water Intake (ml/22-hr)
VEH	5.08 ± 0.25	4.92 ± 0.26	5.07 ± 0.24
FIN-50	5.46 ± 0.03	5.23 ± 0.38	5.32 ± 0.33
FIN-100	6.08 ± 0.29	5.62 ± 0.34	5.45 ± 0.31
Bout Frequency
VEH	6.1 ± 1.2	7.5 ± 1.8	8.3 ± 1.5
FIN-50	2.6 ± 1.1*	4.4 ± 1.8	5.5 ± 1.7
FIN-100	1.3 ± 0.3**	3.6 ± 1.5	3.7 ± 1.5
Bout Size (licks)
VEH	62.4 ± 8.0	85.0 ± 8.6	88.8 ± 13.9
FIN-50	51.7 ± 7.4	87.4 ± 10.0	95.0 ± 13.9
FIN-100	67.3 ± 10.1	85.6 ± 10.5	104.9 ± 15.3

^*P ≤ 0.05,

^**P ≤ 0.01

^***P ≤ 0.001 versus VEH group.